multiplexed sample: Homo sapiens (female, 79 years) substantia nigra tissue associated with Parkinson's disease; Homo sapiens (female, 82 years) middle temporal gyrus tissue associated with cerebral amyloid angiopathy; ... and 10 more samples

multiplexed sample: Homo sapiens (female, 79 years) substantia nigra tissue associated with Parkinson's disease; Homo sapiens (female, 82 years) middle temporal gyrus tissue associated with cerebral amyloid angiopathy; ... and 10 more samples

multiplexed sample: Homo sapiens (male, 53 years) middle temporal gyrus tissue; Homo sapiens (male, 75 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 14 more samples

multiplexed sample: Homo sapiens (male, 53 years) middle temporal gyrus tissue; Homo sapiens (male, 75 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 14 more samples

multiplexed sample: Homo sapiens (female, 79 years) substantia nigra tissue associated with Parkinson's disease; Homo sapiens (female, 82 years) middle temporal gyrus tissue associated with cerebral amyloid angiopathy; ... and 10 more samples

multiplexed sample: Homo sapiens (female, 79 years) substantia nigra tissue associated with Parkinson's disease; Homo sapiens (female, 82 years) middle temporal gyrus tissue associated with cerebral amyloid angiopathy; ... and 10 more samples

multiplexed sample: Homo sapiens (male, 53 years) middle temporal gyrus tissue; Homo sapiens (male, 75 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 14 more samples

multiplexed sample: Homo sapiens (male, 53 years) middle temporal gyrus tissue; Homo sapiens (male, 75 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 14 more samples

multiplexed sample: Homo sapiens (male, 53 years) middle temporal gyrus tissue; Homo sapiens (male, 75 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 14 more samples

multiplexed sample: Homo sapiens (male, 53 years) middle temporal gyrus tissue; Homo sapiens (male, 75 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 14 more samples

multiplexed sample: Homo sapiens (male, 53 years) middle temporal gyrus tissue; Homo sapiens (male, 75 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 14 more samples

multiplexed sample: Homo sapiens (female, 79 years) substantia nigra tissue associated with Parkinson's disease; Homo sapiens (female, 82 years) middle temporal gyrus tissue associated with cerebral amyloid angiopathy; ... and 10 more samples

multiplexed sample: Homo sapiens (female, 79 years) substantia nigra tissue associated with Parkinson's disease; Homo sapiens (female, 82 years) middle temporal gyrus tissue associated with cerebral amyloid angiopathy; ... and 10 more samples

multiplexed sample: Homo sapiens (female, 79 years) substantia nigra tissue associated with Parkinson's disease; Homo sapiens (female, 82 years) middle temporal gyrus tissue associated with cerebral amyloid angiopathy; ... and 10 more samples

multiplexed sample: Homo sapiens (male, 53 years) middle temporal gyrus tissue; Homo sapiens (male, 75 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; ... and 14 more samples

multiplexed sample: Homo sapiens (female, 79 years) substantia nigra tissue associated with Parkinson's disease; Homo sapiens (female, 82 years) middle temporal gyrus tissue associated with cerebral amyloid angiopathy; ... and 10 more samples